Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Ignyta, Inc. (RXDX)

« Back to company index

RXDX Chatter Timeline

Stock Ticker for RXDX

Most Active Tweeters for RXDX

No tweets found

Recent Tweets for RXDX

StockTipRobot @StockTipRobot
My algorithmic computations suggest you invest in Ignyta $RXDX #StockTip
June 16th 2018, 10:06pm
Complexificator @Complexificator
@hotplant Spot on. And $RXDX valuation was supported by ROS1 activity of Entrectinib. Unlike TRK, the ROS1 market a… https://t.co/zNuszNsugq
May 17th 2018, 12:05pm
ConsumerFeed @ConsumerFeed
Somewhat Positive Media Coverage Somewhat Unlikely to Impact Ignyta $RXDX Stock Price https://t.co/HW5CjFaYgg
May 10th 2018, 12:05pm
BoardCentral @BoardCentral
$RXDX "Little known stock set to soar..." on Yahoo! Finance message boards: https://t.co/cplq7VG9Xp
May 9th 2018, 12:05am
ledgerzette @ledgerzette
Ignyta Inc $RXDX Given Consensus Recommendation of “Hold” by Analysts https://t.co/w51UtzsLmx
May 8th 2018, 12:05am
ConsumerFeed @ConsumerFeed
Ignyta Inc $RXDX Receives $25.25 Consensus PT from Brokerages https://t.co/WMjRl8MXzu
May 8th 2018, 12:05am
dakotafinancial @dakotafinancial
Ignyta Inc $RXDX Receives Consensus Rating of “Hold” from Analysts https://t.co/szP5rx7m8Z
May 5th 2018, 8:05pm
WeekHerald @WeekHerald
Ignyta Inc $RXDX Receives Average Rating of “Hold” from Analysts https://t.co/GhUph2YQPb
May 5th 2018, 2:05pm
dispatchtribune @dispatchtribune
Ignyta $RXDX Earning Somewhat Positive News Coverage, Study Finds https://t.co/TK7iJrv2AR
May 5th 2018, 12:05pm
OlympiaReport @OlympiaReport
Ignyta $RXDX Receives News Sentiment Rating of 0.04 https://t.co/ueyv9TDNEo
May 5th 2018, 12:05pm
Orangeman1992 @Orangeman1992
@KlendathuCap I got $RXDX and $JUNO takeovers recently; need more in Biotech space
May 4th 2018, 10:05am
AugustThera @AugustThera
RT @RandySchreck: Thanks to Dr. Jonathan Lim, CEO and Co-founder of $RXDX for speaking at tonight’s @SDEEorg Get to Know Your Neighbor even…
May 4th 2018, 10:05am
RandySchreck @RandySchreck
Thanks to Dr. Jonathan Lim, CEO and Co-founder of $RXDX for speaking at tonight’s @SDEEorg Get to Know Your Neighbo… https://t.co/PvYA71wtCI
May 3rd 2018, 11:05pm
dispatchtribune @dispatchtribune
Ignyta Inc $RXDX Receives $25.25 Consensus PT from Brokerages https://t.co/8SdKxfiDdB
May 3rd 2018, 10:05pm
EnterpriseLeade @EnterpriseLeade
Analysts Set Ignyta Inc $RXDX Target Price at $25.25 https://t.co/7ij4g5AkUz
May 3rd 2018, 10:05pm
ThisLincolnian @ThisLincolnian
Analysts Set Ignyta Inc $RXDX Target Price at $25.25 https://t.co/gS61AONPjL
May 3rd 2018, 10:05am
IlliniJJ @IlliniJJ
@haodongvli Agree, had $RXDX and thought the same thing. I think yesterday's price action was muted by the financi… https://t.co/5rpvW4gp7t
May 2nd 2018, 10:05am
OlympiaReport @OlympiaReport
Ignyta Inc $RXDX Given Average Recommendation of “Hold” by Analysts https://t.co/JMXObT1g4g
April 30th 2018, 9:04am
ZolmaxNews @ZolmaxNews
Ignyta $RXDX Given Media Sentiment Rating of 0.15 https://t.co/f03vMzXM44
April 30th 2018, 6:04am
dakotafinancial @dakotafinancial
Somewhat Positive Media Coverage Somewhat Unlikely to Impact Ignyta $RXDX Stock Price https://t.co/GDvl7gXQo1
April 25th 2018, 5:04am
TheMarketsDaily @TheMarketsDaily
Ignyta $RXDX Receives Coverage Optimism Rating of 0.20 https://t.co/tIketXe0RW
April 25th 2018, 5:04am
ThisLincolnian @ThisLincolnian
Ignyta $RXDX Earning Somewhat Favorable Media Coverage, Analysis Finds https://t.co/SFbNE8ypIt
April 20th 2018, 6:04am
ConsumerFeed @ConsumerFeed
Ignyta $RXDX Getting Somewhat Favorable Press Coverage, Analysis Finds https://t.co/JXPSgG46zt
April 20th 2018, 5:04am
AmericanBanking @AmericanBanking
Ignyta $RXDX Given a $15.00 Price Target at Cantor Fitzgerald https://t.co/ZA1LBC2Zdz #stocks
April 19th 2018, 11:04am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.